Detalhe da pesquisa
1.
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.
J Urol
; 197(6): 1410-1418, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049011
2.
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.
J Urol
; 197(3 Pt 1): 590-595, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27746284
3.
Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.
Hum Mol Genet
; 23(20): 5545-57, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24861552
4.
Combinations of urinary biomarkers for surveillance of patients with incident nonmuscle invasive bladder cancer: the European FP7 UROMOL project.
J Urol
; 189(5): 1945-51, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23201384
5.
A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.
BJU Int
; 109(6): 941-8, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21756281
6.
In-depth investigation of the molecular pathogenesis of bladder cancer in a unique 26-year old patient with extensive multifocal disease: a case report.
BMC Urol
; 10: 5, 2010 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20187926
7.
Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups.
Clin Cancer Res
; 24(7): 1586-1593, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29367430
8.
Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Eur Urol
; 65(2): 360-6, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24018021
9.
Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
Eur Urol
; 64(1): 41-7, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23478169
10.
Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB]).
Eur Urol
; 55(3): 659-67, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18501499